Skip to main content
Premium Trial:

Request an Annual Quote

UK Genomics Research Startup Sano Genetics Raises £500K

NEW YORK (GenomeWeb) — UK genomic research and data-sharing startup Sano Genetics has raised £500,000 ($653,615) in seed financing, the company said today.

The funding was provided by Seedcamp and Cambridge Enterprise, as well as a number of individual investors.

Cambridge-based Sano said it will use the money to support its data-sharing platform, through which individuals can submit their medical history and available genetic data, and be matched with studies that could benefit from the information. The company noted that it works to match participants with research projects that offer cost-free genome sequencing. In exchange, participants receive free personalized health and wellness reports based on their genetic profiles.

Sano — formerly known as Heterogeneous — said it aims to enroll over 10,000 participants to support six new research projects by the end of 2019.

"Our platform allows scientists to do research into personalized medicine and access dynamic health and genetic data sets, while still giving individuals transparency and control throughout the process," Sano CEO Patrick Short said in a statement. "When people trust in the system and see the benefits from their participation, they are more likely to take part again in the future."

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.